Press releases | 23 Feb 2017

Travers Smith advises Lianhe Chemical Technology Co Ltd on its acquisition of the Fine Industries group

Overview

Travers Smith LLP has advised Lianhe Chemical Technology Co Ltd (Lianhetech), a Shenzhen Stock Exchange listed life sciences company, on its acquisition of Fine Industries from NorthEdge Capital and management.

Lianhetech was founded in 1985 and is headquartered in Taizhou, China. It became a publicly listed company on the Shenzhen Stock Exchange in 2008. The acquisition of  the Fine Industries group will bring Lianhetech closer to customers and its key markets and will enable it to expand its portfolio of product development services and manufacturing solutions. The acquisition is conditional on Chinese regulatory approval.

Fine Industries is a European contract manufacturer delivering high quality products and solutions to the chemical and life sciences industries. The Fine Industries group develops and manufactures complex intermediates and actives for its agrochemical and pharma clients, as well as a broad portfolio of solutions for the specialty chemicals market.

The Travers Smith team was led by corporate partner Andrew Gillen with support from associate Fan Yang. Specialist advice on environmental matters was provided by partner Doug Bryden with support from associate John Buttanshaw. Commercial advice was provided by partner Louisa Chambers with support from associates Rowan Armstrong and Elise Jones.